UC's Future Physicians Raise Over $13K by Going Bald for Pediatric Cancer Patients
CINCINNATIThe goal was to raise $11,000 for pediatric cancer researchand isnt it just like University of Cincinnati students to overachieve!
"Were nearing $14,000 and hope to have a few more thousand come in before May, UC College of Medicine second-year student Jamie Lovell said of exceeding their goal at the head-shaving event on St. Baldricks Day, March 18.
Approximately 20 medical students and one faculty member, Edmund Choi, PhD, had their heads shaved to show solidarity for the cause named for a fusion of "St. Patricks Day and "bald.
The St. Baldricks Foundation coordinates worldwide head-shaving events that raise money for childhood cancer research. According to the foundation, since 2005 it has funded over $56.9 million in childhood cancer research. In 2010, volunteers helped raise more than $22.2 million by hosting more than 800 events and shaving more than 38,200 heads.
This is the second year the event has been organized by UC medical students who belong to the pediatric club and the oncology cluband Laura Wexler, MD, senior associate dean of student affairs, seems to have added the title of chief barber to her credentials.
"This kind of charitable support is a very meaningful experience for the students, says Wexler.
Related Stories
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.